Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with st-elevated myocardial infarction undergoing primary coronary intervention

American Journal of Cardiology

Volumn 110, Issue 5, 2012, Pages 621-627

  Akpek, Mahmut ^a   Kaya, Mehmet Gungor ^a   Lam, Yat Yin ^b   Sahin, Omer ^a   Elcik, Deniz ^a   Celik, Turgay ^c   Ergin, Ali ^a   Gibson, Charles Michael ^d  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL LYMPHOCYTE RATIO; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEUTROPHILS; NO-REFLOW PHENOMENON; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864945934     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.04.041     Document Type: Article

References (29)

1. R. Zahorec Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill Bratisl Lek Listy 1 2001 5 14
2. B.D. Horne, J.L. Anderson, J.M. John, A. Weaver, T.L. Bair, K.R. Jensen, D.G. Renlund, J.B. Muhlestein Intermountain Heart Collaborative Study Group Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45 2005 1638 1643
3. J. Núñez, E. Núñez, V. Bodí, J. Sanchis, G. Miñana, L. Mainar, E. Santas, P. Merlos, E. Rumiz, H. Darmofal, A.M. Heatta, A. Llàcer Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction Am J Cardiol 101 2008 747 752
4. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial Phase I findings N Engl J Med 14 1985 932 936
5. M. Akpek, M.G. Kaya, H. Uyarel, M. Yarlioglues, N. Kalay, O. Gunebakmaz, O. Dogdu, I. Ardic, D. Elcik, O. Sahin, A. Oguzhan, A. Ergin, C.M. Gibson The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI Atherosclerosis 219 2011 334 341
6. M. Akpek, D. Elcik, N. Kalay, M. Yarlioglues, O. Dogdu, O. Sahin, I. Ardic, A. Oguzhan, A. Ergin, M.G. Kaya The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI Angiology 2012 [Epub ahead of print]
7. G. Niccoli, G.A. Lanza, C. Spaziani, L. Altamura, E. Romagnoli, A.M. Leone, B. Fusco, C. Trani, F. Burzotta, M.A. Mazzari, R. Mongiardo, L.M. Biasucci, A.G. Rebuzzi, F. Crea Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction Int J Cardiol 117 2007 306 311
8. C.M. Gibson, J.A. de Lemos, S.A. Murphy, S.J. Marble, C.H. McCabe, C.P. Cannon, E.M. Antman, E. Braunwald TIMI Study Group Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation 103 2001 2550 2554
9. P. Libby, P.M. Ridker, A. Maseri Inflammation and atherosclerosis Circulation 9 2002 1135 1143
10. J.M. Le, J. Vilcek Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response Lab Invest 61 1989 588 602
11. R. Topsakal, M.G. Kaya, E. Karakaya, O. Günebakmaz, A. Doan, M.T. Inanç, B. Sarli, I. Ozdoru, A. Ergin Relationship between no-reflow phenomenon and serotonin levels in patients with acute ST-elevation myocardial infarction who underwent primary percutaneous intervention Anadolu Kardiyol Derg 10 2010 253 259
12. S.H. Rezkalla, R.A. Kloner No-reflow phenomenon Circulation 105 2002 656 662
13. M.G. Kaya, H. Uyarel, M. Akpek, N. Kalay, M. Ergelen, E. Ayhan, T. Isik, G. Cicek, D. Elcik, O. Sahin, S.M. Cosgun, A. Oguzhan, M. Eren, C.M. Gibson Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention Am J Cardiol 109 2012 486 491
14. M. Akpek, M.G. Kaya, M. Yarlioglues, O. Dogdu, I. Ardic, O. Sahin, D. Elcik, I. Ozdogru, R. Topsakal, A. Oguzhan, A. Ergin, N. Kalay Relationship between platelet indices and spontaneous echo contrast in patients with mitral stenosis Eur J Echocardiogr 12 2011 865 870
15. M.G. Kaya, M. Akpek, D. Elcik, N. Kalay, M. Yarlioglues, F. Koc, O. Dogdu, O. Sahin, I. Ardic, A. Oguzhan, A. Ergin Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers Am J Cardiol 109 2012 851 855
16. W.J. Dreyer, L.H. Michael, M.S. West, C.W. Smith, R. Rothlein, R.D. Rossen, D.C. Anderson, M.L. Entman Neutrophil accumulation in ischemic canine myocardium Insights into time course, distribution, and mechanism of localization during early reperfusion Circulation 84 1991 400 411
17. T. Celik, A. Iyisoy, H. Kursaklioglu, H. Turhan, S. Kilic, S. Kose, B. Amasyali, E. Isik The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction Coron Artery Dis 16 2005 293 299
18. H. Tomoda, N. Aoki Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction Am Heart J 140 2000 324 328
19. M. Onsrud, E. Thorsby Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations I. Effect on natural killer cell activity Scand J Immunol 13 1981 573 579
20. R.S. Hotchkiss, I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150
21. A. Blum, S. Sclarovsky, E. Rehavia, B. Shohat Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction Am Heart J 127 1994 1226 1230
22. A. Widmer, A.Z. Linka, C.H. Attenhofer Jost, B. Buergi, H.P. Brunner-La Rocca, F. Salomon, B. Seifert, R. Jenni Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia Cardiology 99 2003 25 31
23. R. Dragu, S. Khoury, S. Huri, R. Zuckerman, M. Suleiman, D. Mutlak, Y. Agmon, M. Kapeliovich, R. Beyar, W. Markiewicz, H. Hammerman Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction Atherosclerosis 196 2008 405 412
24. N. Kalay, O. Dogdu, F. Koc, M. Yarlioglues, I. Ardic, M. Akpek, D. Cicek, A. Oguzhan, A. Ergin, M.G. Kaya Hematologic parameters and angiographic progression of coronary atherosclerosis Angiology 63 2012 213 217
25. A. Papa, M. Emdin, C. Passino, C. Michelassi, D. Battaglia, F. Cocci Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease Clin Chim Acta 395 2008 27 31
26. B.K. Duffy, H.S. Gurm, V. Rajagopal, R. Gupta, S.G. Ellis, D.L. Bhatt Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention Am J Cardiol 97 2006 993 996
27. K.H. Cho, M.H. Jeong, K. Ahmed, D. Hachinohe, H.S. Choi, S.Y. Chang, M.C. Kim, S.H. Hwang, K.H. Park, M.G. Lee, J.S. Ko, D.S. Sim, N.S. Yoon, H.J. Yoon, Y.J. Hong, K.H. Kim, J.H. Kim, Y. Ahn, J.G. Cho, J.C. Park, J.C. Kang Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 107 2011 849 856
28. M. Kruk, J. Przyuski,. Kalińczuk, J. Pregowski, T. Deptuch, J. Kadziela, P. Bekta, M. Karcz, M. Demkow, Z. Chmielak, A. Witkowski, W. Ruzyo ANIN Myocardial Infarction Registry Group Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty Circ J 2 2008 205 211
29. A.Z. Arnold, E.J. Topol Assessment of reperfusion after thrombolytic therapy for myocardial infarction Am Heart J 124 1992 441 447